#243 Characteristics and safety in patients with atypical haemolytic uraemic syndrome switching to ravulizumab from eculizumab: a global registry analysis

Schaefer, F., Al-Dakkak, I., Saval, N., Cohen, D., Greenbaum, L. A., & Ariceta, G. (2024). #243 Characteristics and safety in patients with atypical haemolytic uraemic syndrome switching to ravulizumab from eculizumab: a global registry analysis. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.011
Authors:
Franz Schaefer
Imad Al‐Dakkak
Nuria Saval
David J. Cohen
Laurence Greenbaum
Gema Ariceta
Affiliated Authors:
David J. Cohen
Columbia Affiliation:
Subjects:
Diseases Related to Blood Group Variants (OpenAlex Topic)
Role of Complement System in Immune Response (OpenAlex Topic)
Mechanosensitive Ion Channels in Physiology and Disease (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/ndt/gfae069.011
DOI:
10.1093/ndt/gfae069.011
Journal:
Nephrology Dialysis Transplantation
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: